Hayer, Silvia
Medical University of Vienna
6 papers on CoChatORCID 0000-0003-1334-5668
Most cited papers
- Verified
Osteoclasts are essential for TNF-α-mediated joint destruction.
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation
Rheumatoid Arthritis Research and TherapiesBone Metabolism and Diseases
Cited by 474
- Verified
Tumor necrosis factor α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.
Redlich, K., Hayer, S., Maier, A., Dunstan, C. R., Tohidast‐Akrad, M., Lang, S., Türk, B., Pietschmann, P., Woloszczuk, W., Haralambous, S., et al. (2002) · Arthritis & Rheumatism
Rheumatoid Arthritis Research and TherapiesBone Metabolism and Diseases
Cited by 285
- Verified
Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice
Dankbar, B., Fennen, M., Brunert, D., Hayer, S., Frank, S., Wehmeyer, C., Beckmann, D., Paruzel, P., Bertrand, J., Redlich, K., et al. (2015) · Nature Medicine
Bone Metabolism and DiseasesRheumatoid Arthritis Research and Therapies
Cited by 262
- Verified
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.
Schett, G., Redlich, K., Hayer, S., Zwerina, J., Bolon, B., Dunstan, C., Görtz, B., Schulz, A., Bergmeister, H., Kollias, G., et al. (2003) · Arthritis & Rheumatism
Bone Metabolism and DiseasesRheumatoid Arthritis Research and Therapies
Cited by 150
- Verified
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.
Redlich, K., Görtz, B., Hayer, S., Zwerina, J., Doerr, N., Kostenuik, P., Bergmeister, H., Kollias, G., Steiner, G., Smolen, J. S., et al. (2004) · The American Journal of Pathology
Rheumatoid Arthritis Research and TherapiesBone Metabolism and Diseases
Cited by 134
- Verified
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
Herrak, P., Görtz, B., Hayer, S., Redlich, K., Reiter, E., Gasser, J., Bergmeister, H., Kollias, G., Smolen, J. S., & Schett, G. (2004) · Arthritis & Rheumatism
Bone Metabolism and DiseasesRheumatoid Arthritis Research and Therapies
Cited by 110
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free